Bioengineers in Dr. Woodrow’s lab have discovered a faster way to deliver a topical drug that can protect women from contracting HIV. The researchers created a fiber material embedded with the drug through a process called electrospinning that quickly dissolves and releases a potent antiretroviral drug, maraviroc, when it comes into contact with moisture.
UW Bioengineering Summer Camp 2014 concludes, teaches high school students about bioengineering, global health
UW Bioengineering Summer Camp 2014 wraps up, teaching 24 high school students about the field of bioengineering and and the field’s solutions for global health problems.
UW Bioengineering Professor Dr. Valerie Daggett and research team members have designed a peptide structure that can stop harmful changes of proteins in the body that are linked to diseases such as Alzheimer’s, Parkinson’s, heart disease, Type 2 diabetes and Lou Gehrig’s disease (ALS).
UW Bioengineering faculty Charles Murry (joint professor of pathology, bioengineering and medicine/cardiology) and Michael Regnier, as well as adjunct faculty Michael Jensen, MD, director of the Ben Towne Center for Childhood Cancer at Seattle Children’s Research Institute and professor of pediatric hematology-oncology at UW Medicine and Satoshi Minoshima, professor of radiology, were named 2014 UW Presidential Entrepreneurial Faculty Fellows.
Class of 2014 celebrates, David C. Auth delivers keynote speech, at Bioengineering Departmental Graduation Ceremony
The UW Bioengineering Class of 2014 celebrated their impressive accomplishments, David C. Auth delivered keynote speech, at the 2014 Bioengineering Departmental Graduation Ceremony.
UW Bioengineering Ph.D. student, Cameron Ball, and Assistant Professor Kim Woodrow, demonstrate the potential of a new type of product that may help women protect themselves against sexual HIV transmission. Their research, published online ahead of print in the journal Antimicrobial Agents and Chemotherapy (AAC) of the American Society for Microbiology, shows the ability of water-soluble electrospun fiber material to rapidly release maraviroc, an antiretroviral drug. The researchers suggest that their material offers advantages over other anti-HIV microbicides currently in development.
Biomaterials: The Platform Technology of Medical Devices. A 2.5 day introduction to biomaterials, medical devices and biocompatibility presented by the experts. August 14 to August 16, 2014.
UW researchers, including BioE Professor Patrick Stayton and many collaborators from the UW and Fred Hutchinson Cancer Research Center, have created a protein molecule that can prompt cancer cells infected with the Epstein-Barr virus to self-destruct.
UW researchers develop sensor that may be placed permanently in a person’s eye to track changes in pressure, report data wirelessly and monitor for glaucoma
UW Bioengineer Ruikang Wang’s non-invasive method for imaging vascular health holds promise for better diagnosis, monitoring and treatment of diseases.